USA – Affinia Therapeutics, a preclinical biotech developing novel gene therapies for rare diseases and cancer, filed with the Securities and Exchange Commission (SEC) for an initial public offering of…
Read MoreGene therapy biotech Affinia Therapeutics aims to go public, files for a US$100 million IPO
